Ingrid Chemin – Page 15

08/12/2020: Theradiag obtains €1.9 million of non-dilutive financing in the form of a state-guaranteed loan

Post author:Ingrid Chemin
Post published:8 December 2020
Post category:Press Releases

Croissy-Beaubourg, December 8, 2020 – 5:45pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that it has obtained a €1.9 million state-guaranteed loan (Prêt Garanti…

23/09/2020: 2020 Half-year financial report publication (only available in french)

Post author:Ingrid Chemin
Post published:23 September 2020
Post category:Press Releases

Croissy-Beaubourg, September 23, 2020, 5:45pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that its half-year financial report as at 30 June 2020 has been…

Presentation of the 2020 half-year results (only available in french) – 2020, 22nd September

Post author:Ingrid Chemin
Post published:22 September 2020
Post category:Financial presentations

Theradiag will hold a conference call to present H1 2020 results at 9:00am on September 22. To take part, please dial +33 1 72 72 74 03 followed by participant PIN code 24 52 93…